Future-proofing parenteral packaging against nitrosamines

By Datwyler

The discovery of large quantities of nitrosamines in many drugs has led to a high number of product recalls in recent years. This whitepaper discusses the issue of nitrosamine contamination and the response from regulators and industry. Download to learn about the causes of contamination and how to adapt your parenteral packaging – one potential source – to minimise the risk.

Enter your details below to view the free Whitepaper

By downloading this case study, you acknowledge that GlobalData may share your information with Datwyler and that your personal data will be used as described in their Privacy Policy

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.